Cynapsus Therapeutics Inc. — Form D
Cynapsus Therapeutics Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-21. The offering totals $42.9M, of which $14.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-04-21
- Form: D
- Accession: 0001532079-14-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $42.9M
- Amount sold: $14.5M
- Remaining: $28.4M
- Investors: 19
- Date of first sale: 2014-04-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-215923
Issuer
- Name: Cynapsus Therapeutics Inc.
- CIK: 0001532079
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 828 RICHMOND STREET WEST, TORONTO, A6, M6J 1C9
- Phone: 416-703-2449
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Nan Hutchinson | Director | Toronto, A6 |
| Perry Molinoff | Director | DALLAS, TX |
| Ilan Oren | Director | Morrisville, NC |
| Alan D C Ryley | Director | Toronto, A6 |
| Rochelle D C Stenzler | Director | Toronto, A6 |
| Nathan Bryson | Executive Officer | Morristown, NJ |
| DAVID HILL | Director | Charlotte, NC |
| Andrew Williams | Executive Officer | Huntington Beach, CA |
| Julia Levy | Director | Auburn, WA |
| Anthony Giovinazzo | Director | Mississauga, A6 |
| Anthony Giovinazzo | Executive Officer | Mississauga, A6 |
| Margaret Nan Hutchinson | Director | Toronto, A6 |
| Thierry D Bilbault | Executive Officer | Toronto, A6 |
| Tamar D Howson | Director | Toronto, A6 |
| Ronald Hosking | Director | Toronto, A6 |
| Rochelle D Stenzler | Director | Toronto, A6 |
| Ilan Nan Oren | Director | Toronto, A6 |
| Tomer Gold | Director | Toronto, A6 |
| Perry Nan Molinoff | Director | Toronto, A6 |
| Alan D C Torrie | Director | Toronto, A6 |
| Alan Torrie | Director | TORONTO, A6 |
| Alan Ryley | Director | TORONTO, A6 |
| Rochelle Stenzler | Director | TORONTO, A6 |
Other filings by this issuer (9)
More